Before it's here, it's on the Bloomberg Terminal.Learn More
0VB:GRStuttgart
Vascular Biogenics Ltd
No pricing data is available for this time frame
No pricing data is available for this time frame
Before it's here, it's on the Bloomberg Terminal.Learn More
Key Statistics
P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding29.9M
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return--
30 Day Avg Volume--
EPS--
Bloomberg (BEst) EPS Curr Yr-0.8200
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q2/2018:05/14/2018
About Vascular Biogenics Ltd
Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.Address